Clinical Trials | July 10, 2025
82% of people prefer diagnostic centers over hospitals for preventive checkups in India
Insights are drawn from over 30K+ people across 300+ cities including all metro and tier-1 cities
Insights are drawn from over 30K+ people across 300+ cities including all metro and tier-1 cities
The submission is based on data from the STEP UP and STEP UP T2D clinical trials
The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
India’s fertility rate has dropped to 1.9, below the replacement level of 2.1
The company showcased three core programs developed through this platform
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
ARGX-119 is the sixth molecule developed through our Immunology Innovation Program to show proof-of-concept
ART-123 is a recombinant human thrombomodulin approved in Japan in 2008
ISG acknowledged Indegene's strengths in implementing holistic creative workflows, interoperability via robust integration with tech ecosystems
Subscribe To Our Newsletter & Stay Updated
